The Science Behind Breast Milk: Sugars That Program the Immune System
by Mary Ferrari
Human milk oligosaccharides (HMOs) are the third most abundant solid component in human breast milk, following lactose and lipids and they represent one of the most biologically sophisticated elements of early nutrition. Not just simple carbohydrates, HMOs perform a wide range of critical functions that extend far beyond nourishment. They act as powerful prebiotics, selectively stimulating the growth of beneficial gut microbiota such as Bifido bacteria species, which are essential for establishing a healthy intestinal environment in newborns. This early microbial colonization plays a foundational role in shaping immune competence, homeostasis and metabolic health. Later this gives way to a broader population of healthy anaerobic bacteria.
In addition to their prebiotic effects, HMOs exert a protective role against severe neonatal pathologies like necrotizing enterocolitis (NEC), a life-threatening inflammatory condition primarily affecting premature infants. HMOs contribute to this protection by enhancing the integrity of the intestinal barrier and preventing the adhesion of pathogenic bacteria to the gut epithelium. By acting as soluble decoy receptors, they bind harmful microbes and toxins, effectively neutralizing them before they can trigger inflammation or infection.
Even more profound is the ability of HMOs to program the immune system during this critical window of development. Early-life immune education is highly sensitive to environmental inputs, and HMOs guide this process by modulating immune cell responses and promoting tolerance. This immunological programming has long-term effects and is associated with a reduced incidence of allergies and autoimmune diseases later in life. HMOs also play a crucial role in brain development and in the gut barrier’s maturation. Through interactions with gut-associated lymphoid tissue (GALT), HMOs influence the balance between pro-inflammatory and regulatory pathways, fostering a resilient and appropriately calibrated immune system.
HMOs also play a crucial role in brain development. Emerging evidence suggests that these molecules contribute to neurodevelopment. Indirectly, they support the gut-brain axis by shaping the microbiota, which in turn produces metabolites involved in neural signaling and cognitive function. Directly, certain HMOs may be absorbed into systemic circulation and influence brain structure and function, although this remains under active investigation. Along with neurological benefits, HMOs are essential for the maturation of the gut barrier, ensuring proper nutrient absorption while preventing the translocation of toxic substances into the bloodstream.
Breast milk, with its complex and dynamic composition, delivers these benefits in a highly individualized manner. The specific profile of HMOs varies between mothers and across different stages of lactation, reflecting an adaptive system finely tuned to the infant’s needs. This is one of the miracles of human milk: a single class of molecules has such a great impact on the development of the infant.
In this context, the metabolome and metabolomics has emerged as a powerful field of research for advancing our understanding of HMOs and their biological roles. By enabling the comprehensive analysis of metabolites in biological samples, metabolomics provides insights into the functional outcomes of HMO activity. This approach has significant applications in clinical and research settings, allowing for the identification of biomarkers associated with health and disease, as well as the optimization of nutritional interventions.
As research progresses toward a more detailed and comprehensive understanding of HMOs, new opportunities are emerging in the field of neonatal nutrition. One promising direction is the development of targeted supplementation strategies for both breast milk and infant formula. By replicating or enhancing specific HMO profiles, it may become possible to provide each newborn with a more nutritional regimen tailored to their unique physiological needs.
Personalized medicine and personalized nutrition are the keywords driving the application of metabolomics in neonatology for what can be done in the present to protect a newborn particularly in supporting immune development, gut health, and neurodevelopment will affect the future adult as a consequence with profound implications for health outcomes. In this way, HMOs exemplify how early nutritional exposures can shape human health in meaningful and lasting ways.
The Missing Probiotic Your Gut Was Designed For
Human milk is widely recognized as the first functional food encountered in human life due to its rich composition of nutrients and bioactive compounds. Among these, human milk oligosaccharides (HMOs) stand out as one of the most biologically significant components. HMOs are complex carbohydrates that play a critical role in shaping early immune development, gut microbiota, and overall health outcomes. Their multifunctional properties explain many of the long-term protective effects associated with breastfeeding.
HMOs are the third most abundant solid component in human milk, following lactose and lipids, with concentrations typically ranging from 5 to 15 grams per liter in mature milk and even higher in colostrum. These molecules are structurally complex, composed of five primary monosaccharides—glucose, galactose, N-acetylglucosamine, fucose, and sialic acid—which combine in numerous ways to create over 100 distinct HMO structures. This structural diversity allows HMOs to perform a wide range of biological functions making them far more than simple carbohydrates.
One of the defining features of HMOs is that they are not digested by the host. Instead, they pass through the upper gastrointestinal tract intact and reach the colon, where they serve as selective substrates for beneficial gut bacteria. This characteristic places HMOs in the category of prebiotics. By promoting the growth of specific microbial populations—particularly Bifidobacterium species—HMOs help establish a first stage healthy gut microbiome. In breastfed infants, these bacteria can make up as much as 50–90% of the gut microbiota, a dominance mostly attributed to the presence of HMOs.
Beyond their prebiotic role, HMOs contribute to immune defense. They act as decoy receptors, preventing pathogens from binding to intestinal cells, thereby reducing the risk of infections. Additionally, HMOs influence immune cell activity, modulate inflammatory responses, and support the maturation of the intestinal barrier. These combined effects help explain why breastfed infants have lower risks of gastrointestinal infections, allergies, and chronic diseases later in life.
Another important aspect of HMOs is their systemic impact. Although only a small fraction—approximately 1%—is absorbed into circulation, this amount is sufficient to interact with immune cells throughout the body. This suggests that HMOs may influence not only gut health but also broader immune and metabolic pathways. Emerging research also points to potential roles in cognitive development and neurological function.
The composition of HMOs varies widely among individuals and is influenced by factors such as genetics, stage of lactation, and environmental conditions.
HMOs are essential for establishing a balanced gut microbiota, strengthening the intestinal barrier, and guiding immune system development. Their ability to selectively nourish beneficial bacteria while inhibiting pathogens makes them uniquely effective as compared to other prebiotics.
Application to Adults: The Role of HMO Supplementation
Although HMOs are naturally associated with infant nutrition, their biological functions are not limited to early life. The same mechanisms that benefit infants—modulation of the gut microbiome, immune regulation, and anti-inflammatory activity—are highly relevant to adult health as well.
In adults, gut dysbiosis is increasingly linked to conditions such as metabolic disorders, autoimmune diseases, and chronic inflammation. HMO supplementation offers a targeted way to reshape the microbiome by selectively feeding beneficial bacteria like Bifidobacteria, which are often depleted in modern adult populations. Unlike generic prebiotics, HMOs provide a more precise ecological signal potential leading to more predictable and beneficial microbial shifts.
HMOs help strengthen the intestinal barrier and reduce low-grade inflammation, which is a primary driver of many chronic diseases. Their ability to act as decoy receptors support immune resilience.
Most importantly HMOs represent a bridge between early-life programming and adult health. By reintroducing these significant mammalian molecules into the adult diet, supplementation may help restore aspects of immune tolerance and microbial balance that were originally established during infancy but later disrupted or never established at all.
In this regard, HMO supplements are not simply another prebiotic—they are a biologically recognized tool with the potential to rebuild foundational aspects of gut and immune function, extending the benefits of human milk far beyond infancy.
Human milk oligosaccharides as prebiotics
Based on its richness in immune-related components such as human milk, human milk oligosaccharides (HMOs), milk proteins, and lipids, breast milk can be considered the first functional food that humans encounter in their lifetime. According to WHO recommendations breast milk has to be the only food in an infant’s diet in the first six months of age which is then continued up to two years of age with the suitable complementary foods. Regarding breast milk balanced composition, it is considered as the best food of infants thus many studies have been carried out to determine the benefits of breast milk. Based on numerous studies breast milk have a tendency to reduce the risk of type 2 diabetes, obesity, allergies, celiac disease, necrotizing enterocolitis (NEC), gastrointestinal tract infections and some type of cancers. The benefits of breast milk can be explained by its special combination which includes; macronutrients, micronutrients and bioactive components such as immunoglobulins, hormones, growth factors and oligosaccharides. One of the essential bioactive compounds of breast milk is known as human milk oligosaccharides (HMOs). HMOs are unique, bioactive carbohydrates which are identified as the most significant components of breast milk. Since they have structural complexity and multifunctional properties, they are one of the most wondered components of breast milk. HMOs promote the development of the neonatal intestinal immune, and nervous systems. This article briefly describes the history, complex structure and different functions of HMOs and highlight the importance of maternal diet for HMO biosynthesis.